117 related articles for article (PubMed ID: 12747582)
1. Regulatory gene mutations affecting apolipoprotein gene expression: functions and regulatory behavior of known genes may guide future pharmacogenomic approaches to therapy.
Zannis VI; Liu T; Zanni M; Kan HY; Kardassis D
Clin Chem Lab Med; 2003 Apr; 41(4):411-24. PubMed ID: 12747582
[TBL] [Abstract][Full Text] [Related]
2. A hormone response element in the human apolipoprotein CIII (ApoCIII) enhancer is essential for intestinal expression of the ApoA-I and ApoCIII genes and contributes to the hepatic expression of the two linked genes in transgenic mice.
Kan HY; Georgopoulos S; Zannis V
J Biol Chem; 2000 Sep; 275(39):30423-31. PubMed ID: 10893424
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the human apolipoprotein genes.
Zannis VI; Kan HY; Kritis A; Zanni E; Kardassis D
Front Biosci; 2001 Mar; 6():D456-504. PubMed ID: 11229886
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3.
Ladias JA; Hadzopoulou-Cladaras M; Kardassis D; Cardot P; Cheng J; Zannis V; Cladaras C
J Biol Chem; 1992 Aug; 267(22):15849-60. PubMed ID: 1639815
[TBL] [Abstract][Full Text] [Related]
5. Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements. Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites.
Kardassis D; Tzameli I; Hadzopoulou-Cladaras M; Talianidis I; Zannis V
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):222-32. PubMed ID: 9012660
[TBL] [Abstract][Full Text] [Related]
6. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.
Vergnes L; Taniguchi T; Omori K; Zakin MM; Ochoa A
Biochim Biophys Acta; 1997 Oct; 1348(3):299-310. PubMed ID: 9366246
[TBL] [Abstract][Full Text] [Related]
7. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells.
Mietus-Snyder M; Sladek FM; Ginsburg GS; Kuo CF; Ladias JA; Darnell JE; Karathanasis SK
Mol Cell Biol; 1992 Apr; 12(4):1708-18. PubMed ID: 1312668
[TBL] [Abstract][Full Text] [Related]
8. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4.
Ginsburg GS; Ozer J; Karathanasis SK
J Clin Invest; 1995 Jul; 96(1):528-38. PubMed ID: 7615825
[TBL] [Abstract][Full Text] [Related]
9. Direct physical interactions between HNF-4 and Sp1 mediate synergistic transactivation of the apolipoprotein CIII promoter.
Kardassis D; Falvey E; Tsantili P; Hadzopoulou-Cladaras M; Zannis V
Biochemistry; 2002 Jan; 41(4):1217-28. PubMed ID: 11802721
[TBL] [Abstract][Full Text] [Related]
10. Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors.
Lavrentiadou SN; Hadzopoulou-Cladaras M; Kardassis D; Zannis VI
Biochemistry; 1999 Jan; 38(3):964-75. PubMed ID: 9893992
[TBL] [Abstract][Full Text] [Related]
11. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression.
Kritis AA; Ktistaki E; Barda D; Zannis VI; Talianidis I
Nucleic Acids Res; 1993 Dec; 21(25):5882-9. PubMed ID: 8290348
[TBL] [Abstract][Full Text] [Related]
12. The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice.
Georgopoulos S; Kan HY; Reardon-Alulis C; Zannis V
Nucleic Acids Res; 2000 Dec; 28(24):4919-29. PubMed ID: 11121483
[TBL] [Abstract][Full Text] [Related]
13. Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human APOCIII gene.
Talianidis I; Tambakaki A; Toursounova J; Zannis VI
Biochemistry; 1995 Aug; 34(32):10298-309. PubMed ID: 7640286
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of the human apolipoprotein CII promoter by orphan and ligand-dependent nuclear receptors. The regulatory element CIIC is a thyroid hormone response element.
Kardassis D; Sacharidou E; Zannis VI
J Biol Chem; 1998 Jul; 273(28):17810-6. PubMed ID: 9651383
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the hormone-response elements of the proximal ApoA-I promoter, ApoCIII enhancer, and C/EBP binding site of the proximal ApoA-I promoter to the hepatic and intestinal expression of the ApoA-I and ApoCIII genes in transgenic mice.
Kan HY; Georgopoulos S; Zanni M; Shkodrani A; Tzatsos A; Xie HX; Zannis VI
Biochemistry; 2004 May; 43(17):5084-93. PubMed ID: 15109267
[TBL] [Abstract][Full Text] [Related]
16. The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice.
Gao J; Wei Y; Huang Y; Liu D; Liu G; Wu M; Wu L; Zhang Q; Zhang Z; Zhang R; Liang C
J Biol Chem; 2005 Apr; 280(13):12559-66. PubMed ID: 15649902
[TBL] [Abstract][Full Text] [Related]
17. Utilization of recombinant adenovirus and dominant negative mutants to characterize hepatocyte nuclear factor 4-regulated apolipoprotein AI and CIII expression.
Fraser JD; Keller D; Martinez V; Santiso-Mere D; Straney R; Briggs MR
J Biol Chem; 1997 May; 272(21):13892-8. PubMed ID: 9153249
[TBL] [Abstract][Full Text] [Related]
18. A short proximal promoter and the distal hepatic control region-1 (HCR-1) contribute to the liver specificity of the human apolipoprotein C-II gene. Hepatic enhancement by HCR-1 requires two proximal hormone response elements which have different binding specificities for orphan receptors HNF-4, ARP-1, and EAR-2.
Vorgia P; Zannis VI; Kardassis D
J Biol Chem; 1998 Feb; 273(7):4188-96. PubMed ID: 9461615
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene.
Ktistaki E; Lacorte JM; Katrakili N; Zannis VI; Talianidis I
Nucleic Acids Res; 1994 Nov; 22(22):4689-96. PubMed ID: 7984419
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]